GTC Biotherapeutics (fka GTCB)

[nivasvs]

<On the other hand, the FXa inhibitors being developed by Big Pharma are pills whose economic justification comes mostly from their potential in chronic-use settings.>

Not all the FXa are oral pills nor are they for chronic use.

Example is Sanofi's Otamixaban, an IV administration for ACS indication (Acute Coronary Syndrome).

Sorry for the nitpicking Dew.:)